Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(24 sites)

United States

HonorHealth Bob Bove Neuroscience Institute, Scottsdale, Arizona

Mills Peninsula Medical Center, Burlingame, California

MemorialCare Long Beach Medical Center, Long Beach, California

California Pacific Medical Center, San Francisco, California

Pacific Neurosciences Institute at Saint John's Physician Partners, Torrance, California

Baptist Health Medical Center, Jacksonville, Florida

Henry Ford Hospital, Detroit, Michigan

Washington University in St. Louis, St Louis, Missouri

Cooper University Hospital, Camden, New Jersey

WakeMed, Raleigh, North Carolina

The Ohio State University, Columbus, Ohio

ProMedica Toledo Hospital, Toledo, Ohio

Mercy Health St. Vincent Medical Center, Toledo, Ohio

Valley Baptist Medical Center - Harlingen, Harlingen, Texas

Memorial Hermann Hospital, Houston, Texas

Australia

John Hunter Hospital, New Lambton Heights, New South Wales

Princess Alexandra Hospital, Woolloongabba, Queensland

Royal Adelaide Hospital, Adelaide, South Australia

Monash Medical Centre, Clayton, Victoria

The Royal Melbourne Hospital, Parkville, Victoria

Fiona Stanley Hospital, Murdoch, Western Australia

Canada

University of Calgary, Calgary, Alberta

University of Alberta Hospital, Edmonton, Alberta

Ottawa Hospital Research Institute, Ottawa, Ontario